Michael Aitchison

2.9k total citations
45 papers, 866 citations indexed

About

Michael Aitchison is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Michael Aitchison has authored 45 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 22 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Michael Aitchison's work include Renal cell carcinoma treatment (29 papers), Renal and related cancers (19 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Michael Aitchison is often cited by papers focused on Renal cell carcinoma treatment (29 papers), Renal and related cancers (19 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Michael Aitchison collaborates with scholars based in United Kingdom, Netherlands and Australia. Michael Aitchison's co-authors include I G Finlay, E. Bromwich, Gavin W.A. Lamb, P. Vasey, Ruth F. McKee, F.W. Poon, P.J.K. Paterson, G.R. Mufti, R. Carter and Grenville Oades and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Michael Aitchison

43 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Aitchison United Kingdom 19 444 395 293 233 181 45 866
Michael Froehner Germany 18 520 1.2× 255 0.6× 348 1.2× 172 0.7× 178 1.0× 66 1.0k
Gustavo de la Roza United States 15 705 1.6× 261 0.7× 232 0.8× 283 1.2× 249 1.4× 39 1.1k
Sven Wenske United States 21 684 1.5× 188 0.5× 283 1.0× 172 0.7× 185 1.0× 41 1.2k
Vito Mancini Italy 18 294 0.7× 173 0.4× 240 0.8× 140 0.6× 200 1.1× 64 805
S Conquy France 11 552 1.2× 274 0.7× 233 0.8× 67 0.3× 204 1.1× 48 802
Xiaoqing Xu China 17 223 0.5× 177 0.4× 147 0.5× 209 0.9× 54 0.3× 48 769
Reza Sari Motlagh Austria 20 582 1.3× 143 0.4× 519 1.8× 364 1.6× 103 0.6× 99 1.2k
J. Erik Busby United States 16 350 0.8× 207 0.5× 582 2.0× 120 0.5× 211 1.2× 27 1.1k
Shigehiko Koga Japan 15 242 0.5× 240 0.6× 148 0.5× 150 0.6× 43 0.2× 35 637
S. Melchior Germany 11 380 0.9× 336 0.9× 139 0.5× 149 0.6× 67 0.4× 34 672

Countries citing papers authored by Michael Aitchison

Since Specialization
Citations

This map shows the geographic impact of Michael Aitchison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Aitchison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Aitchison more than expected).

Fields of papers citing papers by Michael Aitchison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Aitchison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Aitchison. The network helps show where Michael Aitchison may publish in the future.

Co-authorship network of co-authors of Michael Aitchison

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Aitchison. A scholar is included among the top collaborators of Michael Aitchison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Aitchison. Michael Aitchison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neves, Joana B., John Withington, Sarah Fowler, et al.. (2018). Contemporary surgical management of renal oncocytoma: a nation's outcome. British Journal of Urology. 121(6). 893–899. 24 indexed citations
2.
Soomro, Naeem, Jan Lecouturier, Deborah Stocken, et al.. (2017). Surveillance versus ablation for incidentally diagnosed small renal tumours: the SURAB feasibility RCT. Health Technology Assessment. 21(81). 1–68. 14 indexed citations
3.
Roseweir, Antonia K., Tahir Qayyum, Rachel Hammond, et al.. (2016). Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients. BMC Cancer. 16(1). 229–229. 31 indexed citations
4.
Stewart, Grant D., Fiach C. O’Mahony, Alexander Laird, et al.. (2015). Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal Cancer. Clinical Cancer Research. 21(18). 4212–4223. 29 indexed citations
5.
Stewart, Grant D., Fiach C. O’Mahony, Alexander Laird, et al.. (2014). Carbonic Anhydrase 9 Expression Increases with Vascular Endothelial Growth Factor–Targeted Therapy and Is Predictive of Outcome in Metastatic Clear Cell Renal Cancer. European Urology. 66(5). 956–963. 32 indexed citations
6.
7.
Venugopal, Balaji, et al.. (2013). Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma. BMC Urology. 13(1). 26–26. 13 indexed citations
8.
Qayyum, Tahir, Peter McArdle, Clare Orange, et al.. (2013). Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?. SpringerPlus. 2(1). 378–378. 9 indexed citations
9.
Stewart, Grant D., Fiach C. O’Mahony, Lél Eöry, et al.. (2012). Proteomic analysis of pre- and post-sunitinib treated renal cancer tissue to assess tumor heterogeneity and differential protein expression.. Journal of Clinical Oncology. 30(5_suppl). 388–388. 2 indexed citations
10.
Qayyum, Tahir, Peter McArdle, Gavin W.A. Lamb, et al.. (2012). Expression and prognostic significance of Src family members in renal clear cell carcinoma. British Journal of Cancer. 107(5). 856–863. 30 indexed citations
11.
Qayyum, Tahir, Peter McArdle, Gavin W.A. Lamb, et al.. (2012). Prospective Study of the Role of Inflammation in Renal Cancer. Urologia Internationalis. 88(3). 277–281. 27 indexed citations
12.
13.
Aitchison, Michael, Donald C. McMillan, & Sara Ramsey. (2005). Re: C-reactive protein: A biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy - A. Casamassima, M. Picciariello, M. Quaranta, R. berardino, C. Ranieri, A. Paradiso, V. Lo. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 1 indexed citations
14.
Lamb, Gavin W.A., E. Bromwich, P. Vasey, & Michael Aitchison. (2004). Management of renal masses in patients medically unsuitable for nephrectomy—natural history, complications, and outcome. Urology. 64(5). 909–913. 87 indexed citations
15.
Bromwich, E. & Michael Aitchison. (2002). How should patients be followed up after radical nephrectomy for renal cell cancer?. British Journal of Urology. 89(1). 1–4. 1 indexed citations
16.
Bromwich, E., et al.. (2002). Cytoreductive nephrectomy: is it a realistic option in patients with renal cancer?. British Journal of Urology. 89(6). 523–525. 29 indexed citations
17.
Gorham, S.D., et al.. (1993). Collagen arrangements in ureter. Urological Research. 21(5). 325–328. 6 indexed citations
18.
Aitchison, Michael, et al.. (1991). Impaired Anal Sensation and Early Diabetic Faecal Incontinence. Diabetic Medicine. 8(10). 960–963. 19 indexed citations
19.
Aitchison, Michael, G.R. Mufti, John Farrell, P.J.K. Paterson, & R. Scott. (1990). Granulomatous Orchitis. British Journal of Urology. 66(3). 312–314. 23 indexed citations
20.
Aitchison, Michael, et al.. (1989). Epidermoid Cyst of the Testis. British Journal of Urology. 63(3). 324–324.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Froehner Breakdown of academic impact, for papers by Gustavo de la Roza Breakdown of academic impact, for papers by Sven Wenske Breakdown of academic impact, for papers by Vito Mancini Breakdown of academic impact, for papers by S Conquy Breakdown of academic impact, for papers by Xiaoqing Xu Breakdown of academic impact, for papers by Reza Sari Motlagh Breakdown of academic impact, for papers by J. Erik Busby Breakdown of academic impact, for papers by Shigehiko Koga Breakdown of academic impact, for papers by S. Melchior
Rankless by CCL
2026